FDA Center for Tobacco Products Issues Warning Letter to Global Tobacco
April 08, 2026
April 08, 2026
WASHINGTON, April 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Global Tobacco, LLC from its Center for Tobacco Products:
* * *
Recipient: Global Tobacco, LLC, 2861 Congressman Lane, Suite 300, Dallas, TX 75220, United States
Issuing Office: Center for Tobacco Products, United States
WARNING LETTER
To Whom It May Concern:
The Center for Tobacco . . .
* * *
Recipient: Global Tobacco, LLC, 2861 Congressman Lane, Suite 300, Dallas, TX 75220, United States
Issuing Office: Center for Tobacco Products, United States
WARNING LETTER
To Whom It May Concern:
The Center for Tobacco . . .
